Results 191 to 200 of about 6,015 (212)

The Interaction Between Suxamethonium and the Succeeding Non-Depolarizing Neuromuscular Blocking Agent

Survey of Anesthesiology, 1991
J. SWEN, H. W. J. ROOT, A. BENCINI, J. M. KET, J. HERMANS, S. AGOSTON   +5 more
openaire   +1 more source

Targeting RNA to treat neuromuscular disease

Nature Reviews Drug Discovery, 2011
Francesco Muntoni, Matthew J A Wood
exaly  

The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.

Archives internationales de pharmacodynamie et de therapie, 1974
SCAF, AHJ, VANDENAK.J, [No Value], BERENDS, F   +2 more
openaire   +2 more sources

Neuromuscular blocking agents and reversal agents

Anaesthesia and Intensive Care Medicine, 2021
exaly  

[Mivacurium. A non-depolarizing neuromuscular blocking agent with short-lasting effect].

Ugeskrift for laeger, 1998
D, Ostergaard, J V, Mogensen
openaire   +1 more source

Resistance to non-depolarizing neuromuscular blocking agents.

British journal of anaesthesia, 1992
openaire   +1 more source

Kanfer Neuromuscular or Handwriting Test

Ca-A Cancer Journal for Clinicians, 1971
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Quantification of the Aminosteroidal Non-Depolarizing Neuromuscular Blocking Agents Rocuronium and Vecuronium in Plasma with Liquid Chromatography-Tandem Mass Spectroscopy

Clinical Chemistry, 2000
exaly